A single centre phase I trial of APG 101 in healthy volunteers.

Trial Profile

A single centre phase I trial of APG 101 in healthy volunteers.

Completed
Phase of Trial: Phase I

Latest Information Update: 13 May 2009

At a glance

  • Drugs Asunercept (Primary)
  • Indications Glioblastoma; Graft-versus-host disease; Myelodysplastic syndromes; Myocardial infarction; Solid tumours; Stroke
  • Focus Adverse reactions
  • Sponsors Apogenix
  • Most Recent Events

    • 13 May 2009 New trial record.
    • 13 May 2009 All endpoints have been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top